Quanterix Corporation

NASDAQ

Market Cap.

208.66M

Avg. Volume

743.95K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Quanterix Corporation

Quanterix Corporation News

Quanterix Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Devices
quanterix.com

About Quanterix Corporation

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Quanterix Corporation Earnings & Revenue

Quanterix Corporation Financials

Table Compare

Compare QTRX metrics with:

   

Earnings & Growth

QTRX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

QTRX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

QTRX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

QTRX

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Quanterix Corporation Income

Quanterix Corporation Balance Sheet

Quanterix Corporation Cash Flow

Quanterix Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioNeutral
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Quanterix Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Quanterix Corporation Executives

NameRole
Dr. Masoud Toloue Ph.D.President, Chief Executive Officer & Director
Dr. Mark T. Roskey Ph.D.Chief Science & Collaboration Officer
Dr. David R. Walt Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Independent Director
Dr. Michael Miller Ph.D.Chief Operating Officer
Mr. Darrin Crisitello M.B.A.Senior Vice President & Chief Commercial Officer
NameRoleGenderDate of BirthPay
Dr. Masoud Toloue Ph.D.President, Chief Executive Officer & Director19811.23M
Dr. Mark T. Roskey Ph.D.Chief Science & Collaboration Officer1960495.03K
Dr. David R. Walt Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Independent Director195347.5K
Dr. Michael Miller Ph.D.Chief Operating Officer

--

Mr. Darrin Crisitello M.B.A.Senior Vice President & Chief Commercial OfficerMale

--

Quanterix Corporation Insider Trades

Date30 Apr
NameToloue Masoud
RolePresident & CEO
TransactionDisposed
TypeF-InKind
Shares254
Date15 Apr
NameSriram Vandana
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares229
Date15 Apr
NameToloue Masoud
RolePresident & CEO
TransactionDisposed
TypeF-InKind
Shares1242
Date1 Apr
NameWALT DAVID R
RoleDirector
TransactionAcquired
TypeA-Award
Shares2156
Date1 Apr
NameMEISTER PAUL M
RoleDirector
TransactionAcquired
TypeA-Award
Shares2479
DateNameRoleTransactionTypeShares
30 AprToloue MasoudPresident & CEODisposedF-InKind254
15 AprSriram VandanaChief Financial OfficerDisposedF-InKind229
15 AprToloue MasoudPresident & CEODisposedF-InKind1242
1 AprWALT DAVID RDirectorAcquiredA-Award2156
1 AprMEISTER PAUL MDirectorAcquiredA-Award2479

Discover More

Streamlined Academy

Quanterix Corporation

NASDAQ

Market Cap.

208.66M

Avg. Volume

743.95K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Quanterix Corporation News

Quanterix Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Quanterix Corporation Earnings & Revenue

Quanterix Corporation Income

Quanterix Corporation Balance Sheet

Quanterix Corporation Cash Flow

Quanterix Corporation Financials Over Time

Quanterix Corporation Executives

NameRole
Dr. Masoud Toloue Ph.D.President, Chief Executive Officer & Director
Dr. Mark T. Roskey Ph.D.Chief Science & Collaboration Officer
Dr. David R. Walt Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Independent Director
Dr. Michael Miller Ph.D.Chief Operating Officer
Mr. Darrin Crisitello M.B.A.Senior Vice President & Chief Commercial Officer
NameRoleGenderDate of BirthPay
Dr. Masoud Toloue Ph.D.President, Chief Executive Officer & Director19811.23M
Dr. Mark T. Roskey Ph.D.Chief Science & Collaboration Officer1960495.03K
Dr. David R. Walt Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Independent Director195347.5K
Dr. Michael Miller Ph.D.Chief Operating Officer

--

Mr. Darrin Crisitello M.B.A.Senior Vice President & Chief Commercial OfficerMale

--

Quanterix Corporation Insider Trades

Date30 Apr
NameToloue Masoud
RolePresident & CEO
TransactionDisposed
TypeF-InKind
Shares254
Date15 Apr
NameSriram Vandana
RoleChief Financial Officer
TransactionDisposed
TypeF-InKind
Shares229
Date15 Apr
NameToloue Masoud
RolePresident & CEO
TransactionDisposed
TypeF-InKind
Shares1242
Date1 Apr
NameWALT DAVID R
RoleDirector
TransactionAcquired
TypeA-Award
Shares2156
Date1 Apr
NameMEISTER PAUL M
RoleDirector
TransactionAcquired
TypeA-Award
Shares2479
DateNameRoleTransactionTypeShares
30 AprToloue MasoudPresident & CEODisposedF-InKind254
15 AprSriram VandanaChief Financial OfficerDisposedF-InKind229
15 AprToloue MasoudPresident & CEODisposedF-InKind1242
1 AprWALT DAVID RDirectorAcquiredA-Award2156
1 AprMEISTER PAUL MDirectorAcquiredA-Award2479

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
quanterix.com

About Quanterix Corporation

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Quanterix Corporation

Quanterix Corporation Financials

Table Compare

Compare QTRX metrics with:

   

Earnings & Growth

QTRX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

QTRX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

QTRX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

QTRX

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Quanterix Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioNeutral
Price/Earnings RatioStrong Sell
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)